[Recalled] Merge HEMO software. — The International Normalized Ratio (INR) value displayed in the study report do… | FDA 2012-07-02
Regulators flagged this product in an official safety action. Here is what the notice says and what it means for owners.
Recall details
| Product | Merge HEMO software. |
|---|---|
| Brand / manufacturer | Merge Healthcare, Inc. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-2341-2016 |
| Country of notice | United States |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 02 July 2012 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: The International Normalized Ratio (INR) value displayed in the study report does not match the value that is imported on the pre-procedure labs screen from HL7
This Class II recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from Merge Healthcare, Inc.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.